Novavax Wins COVID-19 Vaccine Contract With U.S. Department of Defense
Published
In return for up to $60 million in funding, the biotech will deliver 10 million doses of NVX-CoV2373 to the military in 2020.
Full ArticlePublished
In return for up to $60 million in funding, the biotech will deliver 10 million doses of NVX-CoV2373 to the military in 2020.
Full ArticleThe biotech also said it will announce results from phase 1 testing of its COVID-19 vaccine candidate, INO-4800, by the end of..
Novavax Inc said on Thursday the U.S. Department of Defense (DoD) will give the late-stage biotech company up to $60 million to..